Barcelona Institute for Global Health, ISGlobal, Universitat Pompeu Fabra, CIBER Epidemiología y Salud Pública, Barcelona, Spain.
Pulmonary Division, Heart Institute (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil.
PLoS Med. 2022 Aug 25;19(8):e1004079. doi: 10.1371/journal.pmed.1004079. eCollection 2022 Aug.
The influence of urbanicity on hypertension prevalence remains poorly understood. We conducted a systematic review and meta-analysis to assess the difference in hypertension prevalence between urban and rural areas in low-income and middle-income countries (LMICs), where the most pronounced urbanisation is underway.
We searched PubMed, Web of Science, Scopus, and Embase, from 01/01/1990 to 10/03/2022. We included population-based studies with ≥400 participants 15 years and older, selected by using a valid sampling technique, from LMICs that reported the urban-rural difference in hypertension prevalence using similar blood pressure measurements. We excluded abstracts, reviews, non-English studies, and those with exclusively self-reported hypertension prevalence. Study selection, quality assessment, and data extraction were performed by 2 independent reviewers following a standardised protocol. Our primary outcome was the urban minus rural prevalence of hypertension. Hypertension was defined as systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure as ≥90 mm Hg and could include use of antihypertensive medication, self-reported diagnosis, or both. We investigated heterogeneity using study-level and socioeconomic country-level indicators. We conducted meta-analysis and meta-regression using random-effects models. This systematic review and meta-analysis has been registered with PROSPERO (CRD42018091671). We included 299 surveys from 66 LMICs, including 19,770,946 participants (mean age 45.4 ± SD = 9 years, 53.0% females and 63.1% from rural areas). The pooled prevalence of hypertension was 30.5% (95% CI, 28.9, 32.0) in urban areas and 27.9% (95% CI, 26.3, 29.6) in rural areas, resulting in a pooled urban-rural difference of 2.45% (95% CI, 1.57, 3.33, I-square: 99.71%, tau-square: 0.00524, Pheterogeneity < 0.001). Hypertension prevalence increased over time and the rate of change was greater in rural compared to urban areas, resulting in a pooled urban-rural difference of 5.75% (95% CI, 4.02, 7.48) in the period 1990 to 2004 and 1.38% (95% CI, 0.40, 2.37) in the period 2005 to 2020, p < 0.001 for time period. We observed substantial heterogeneity in the urban-rural difference of hypertension, which was partially explained by urban-rural definition, probably high risk of bias in sampling, country income status, region, and socioeconomic indicators. The urban-rural difference was 5.67% (95% CI, 4.22, 7.13) in low, 2.74% (95% CI, 1.41, 4.07) in lower-middle and -1.22% (95% CI, -2.73, 0.28) in upper-middle-income countries in the period 1990 to 2020, p < 0.001 for country income. The urban-rural difference was highest for South Asia (7.50%, 95% CI, 5.73, 9.26), followed by sub-Saharan Africa (4.24%, 95% CI, 2.62, 5.86) and reversed for Europe and Central Asia (-6.04%, 95% CI, -9.06, -3.01), in the period 1990 to 2020, p < 0.001 for region. Finally, the urban-rural difference in hypertension prevalence decreased nonlinearly with improvements in Human Development Index and infant mortality rate. Limitations included lack of data available from all LMICs and variability in urban and rural definitions in the literature.
The prevalence of hypertension in LMICs increased between 1990 and 2020 in both urban and rural areas, but with a stronger trend in rural areas. The urban minus rural hypertension difference decreased with time, and with country-level socioeconomic development. Focused action, particularly in rural areas, is needed to tackle the burden of hypertension in LMICs.
城市人口对高血压患病率的影响仍知之甚少。我们进行了一项系统评价和荟萃分析,以评估在城市化进程最显著的中低收入国家(LMICs)中城乡高血压患病率的差异。
我们检索了 PubMed、Web of Science、Scopus 和 Embase,时间范围为 1990 年 1 月 1 日至 2022 年 10 月 3 日。我们纳入了基于人群的研究,这些研究的参与者年龄在 15 岁及以上,采用有效的抽样技术,来自 LMICs,使用类似的血压测量方法报告了城乡高血压患病率的差异。我们排除了摘要、综述、非英语研究以及仅报告自我报告的高血压患病率的研究。研究选择、质量评估和数据提取由 2 名独立评审员按照标准化方案进行。我们的主要结局是城乡高血压患病率的差异。高血压定义为收缩压≥140mmHg 和/或舒张压≥90mmHg,可包括使用降压药物、自我报告的诊断或两者兼有。我们使用研究层面和社会经济国家层面的指标来评估异质性。我们使用随机效应模型进行荟萃分析和荟萃回归。本系统评价和荟萃分析已在 PROSPERO(CRD42018091671)注册。我们纳入了来自 66 个 LMICs 的 299 项调查,共纳入 19770946 名参与者(平均年龄 45.4±9 岁,53.0%为女性,63.1%来自农村地区)。城市地区高血压患病率为 30.5%(95%CI,28.9,32.0),农村地区为 27.9%(95%CI,26.3,29.6),城乡差异为 2.45%(95%CI,1.57,3.33,I-square:99.71%,tau-square:0.00524,P 异质性 < 0.001)。高血压患病率随时间推移而增加,农村地区的变化速度快于城市地区,因此在 1990 年至 2004 年期间城乡差异为 5.75%(95%CI,4.02,7.48),在 2005 年至 2020 年期间为 1.38%(95%CI,0.40,2.37),P<0.001 时间点。我们观察到城乡高血压差异存在很大的异质性,部分原因是城乡定义、抽样高偏倚风险、国家收入状况、区域和社会经济指标。在 1990 年至 2020 年期间,低、中低收入和高收入国家城乡差异分别为 5.67%(95%CI,4.22,7.13)、2.74%(95%CI,1.41,4.07)和-1.22%(95%CI,-2.73,0.28),P<0.001 国家收入。在 1990 年至 2020 年期间,城乡高血压差异最大的是南亚(7.50%,95%CI,5.73,9.26),其次是撒哈拉以南非洲(4.24%,95%CI,2.62,5.86),而欧洲和中亚则相反(-6.04%,95%CI,-9.06,-3.01),P<0.001 地区。最后,高血压患病率城乡差异随人类发展指数和婴儿死亡率的改善呈非线性下降。局限性包括并非所有 LMICs 都有可用数据,以及文献中城乡定义的差异。
1990 年至 2020 年间,中低收入国家城乡地区高血压患病率均有所上升,但农村地区上升趋势更为明显。城乡高血压患病率差异随时间缩小,与国家社会经济发展水平相关。需要在农村地区采取有针对性的行动,特别是在农村地区,以应对中低收入国家高血压负担。